Dr. Ishita B. Sen

Director & Head, Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute (FMRI), Gurgaon. Over two decades of experience leading high-volume PET/CT and theranostics programmes; contributor to α-therapy perspectives and consensus work.

Highlights & Publications

  • Perspective on charting targeted α-therapy pathways (2024).
  • IAEA consensus work on Ac-225-PSMA in mCRPC (2024).
  • Occupational radiation dose assessment in α-workflows (2018).

Dr. Dharmender Malik

Senior Consultant, Department of Nuclear Medicine, FMRI, Gurgaon; prior leadership at Paras (HOD) and academic work at Sir Ganga Ram Hospital (CARING). Research spans nuclear cardiology phase analysis, neuro-oncology PET/CT, and β/α theranostics including upfront Lu-177-PSMA case experience.

Highlights & Publications

  • Phase Analysis in nuclear cardiology — methods & applications (2019).
  • Upfront 177Lu-PSMA radioligand therapy — case report (2022).
  • FDG PET/CT in recurrent glioblastoma — imaging nuances (2021).
  • Lead-203 VMT-α-NET scintigraphy — targeted α therapy roadmap (2024).
  • FDG PET/CT score for diagnosing malignant pleural effusion — commentary (2020).